Related Experiment Videos

Disruption of the Keap1-containing ubiquitination complex as an antioxidant therapy

Jonathan T Kern1, Mark Hannink, J Fred Hess

  • 1Neuroscience Drug Discovery, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA. jonathan_kern@merck.com

Insights

Targeting Keap1 protein interactions could activate Nrf2, promoting antioxidant gene transcription. This approach may enhance cellular defense against oxidative stress disorders like cancer and Parkinson's disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • Oxidative stress contributes to diseases like cancer and Parkinson's.
  • Antioxidant Response Element (ARE) genes protect cells from oxidative damage.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) activates ARE genes.
  • Kelch-like ECH-associated protein 1 (Keap1) regulates Nrf2 stability via ubiquitination and proteasomal degradation.

Purpose of the Study:

  • To propose a novel therapeutic strategy targeting the Keap1-Nrf2 pathway.
  • To explore small molecule modulation of Keap1 protein:protein interactions.
  • To enhance Nrf2 nuclear accumulation and subsequent ARE-dependent gene transcription.

Main Methods:

  • Elucidation of the structural interactions within the Keap1-ubiquitin ligase complex.
  • Hypothesizing small molecule-mediated disruption of Keap1 interactions.
  • Focus on promoting Nrf2 nuclear translocation.

Main Results:

  • Detailed structural studies of the Keap1 complex have been recently published.
  • This work proposes a mechanism for modulating Keap1 interactions.
  • The proposed mechanism aims to increase Nrf2 levels and activity.

Conclusions:

  • Modulating Keap1 protein:protein interactions is a potential therapeutic avenue.
  • This strategy could lead to increased nuclear accumulation of Nrf2.
  • Enhanced transcription of ARE-dependent genes may improve cellular resistance to oxidative stress.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...